|

Erdafitinib Clinical Trials

1 actively recruiting trial

▼ -1 trial since August 2026

Also known as: Balversa, JNJ 42756493, JNJ-42756493, JNJ42756493

Pipeline

Phase 2: 1

Top Sponsors

  • The Netherlands Cancer Institute1

Indications

  • Neoplasia1
  • Tumors1
  • Neoplasm1
  • Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.